COLLPLANT BIOTECH. IS-01 (CPT) — Cash Flow-to-Debt Ratio
COLLPLANT BIOTECH. IS-01 (CPT) has a Cash Flow-to-Debt Ratio of -0.62x as of December 2025, meaning its operating cash flow of €-2.94 Million could theoretically repay -1% of its total liabilities (€4.70 Million) in one year. See COLLPLANT BIOTECH. IS-01 free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
COLLPLANT BIOTECH. IS-01 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for COLLPLANT BIOTECH. IS-01 across 5 annual periods. Also explore CPT net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for COLLPLANT BIOTECH. IS-01 (2021–2025)
Year-by-year debt coverage analysis for COLLPLANT BIOTECH. IS-01. For market capitalisation and broader financial context, see COLLPLANT BIOTECH. IS-01 stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.00x | €-9.42 Million | €4.70 Million | ▲ +25.5% |
| 2024 | -2.69x | €-14.09 Million | €5.25 Million | ▼ -462.7% |
| 2023 | -0.48x | €-2.76 Million | €5.79 Million | ▲ +80.9% |
| 2022 | -2.50x | €-13.70 Million | €5.49 Million | ▼ -709.2% |
| 2021 | 0.41x | €2.50 Million | €6.10 Million | — |